MASANUMAS 7(SAPT) – 120 TAB
₹ 380.95 Original price was: ₹ 380.95.₹ 304.76Current price is: ₹ 304.76.
Fast & Reliable Delivery
100% Genuine Product
Secure Payment Options
Dedicated Customer Support
Follow us on Social Media
Disclaimer:
Product details, including colors and availability, may vary slightly. Always read descriptions carefully before purchase....
Read More
Product details, including colors and availability, may vary slightly. Always read descriptions carefully before purchase. We do not encourage self-medication. Information provided on this site or linked sources is not a substitute for professional medical advice. Please consult a qualified healthcare provider before using any medication, supplement, or booster. A proper medical check-up is essential to determine the correct dosage, frequency, and duration based on individual needs. Returns are subject to our return policy.
Masanumas 7 Tablets are carefully formulated using selected herbal extracts recommended in Ayurvedic literature to provide essential nourishment for both the mother and the foetus during the seventh month of pregnancy. This stage is critical for foetal lung maturity, skin development, and immune strengthening, making proper nutrition crucial.
Key Benefits:
✔ Supports Lung & Respiratory System Maturation – Helps in preparing the foetus for independent breathing after birth.
✔ Promotes Skin & Hair Development – Nourishes the foetal skin, reducing dryness and enhancing softness.
✔ Enhances Blood Circulation & Oxygen Supply – Ensures optimal nourishment and growth of the baby.
✔ Boosts Maternal Strength & Immunity – Supports better energy levels and overall well-being.
✔ Prepares the Body for Labor – Helps in strengthening the uterus and pelvic muscles for a smoother delivery.
Indications:
Nourishment for Foetus & Mother (Seventh Month of Pregnancy)
Supports Lung & Skin Development
Enhances Blood Circulation & Foetal Growth
Prepares for Labor & Reduces Fatigue
Dosage:
As directed by the physician.
Reviews
Clear filtersThere are no reviews yet.